Live Breaking News & Updates on Australian Imaging Biomarkers

Stay updated with breaking news from Australian imaging biomarkers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novel deep learning model to assess Alzheimer's disease progression risk

Patterns in the Alzheimer's disease (AD) trajectory using Mendelian randomization (MR) and deep learning (DL). ....

Andrey Suslov Shutterstock , Ad Neuroimaging Initiative , Clinical Medicine , Australian Imaging Biomarkers , Lifestyle Study , Alzheimer 39s Disease , Deep Learning ,

Is Service-Related Traumatic Brain Injury in Veterans a Prelude to Alzheimer's Disease?

Traumatic brain injury (TBI) is common among military veterans and has been associated with an increased risk of dementia. Whether this is due to an i.. ....

Republic Of , United States , Davidl Brody , Tia Cummins , New Rochelle , Vincent Dor , Glucose Metabolism , Service Related Traumatic Brain Injury , Vietnam War Veterans , Australian Imaging Biomarkers , Lifestyle Study , Aging Veterans Study ,

The natural history of tau accumulation and the impact of disease stage and reference region on the magnitude and effect size of regional change

Researchers performed serial tau imaging with 18F-MK6240 to detect tau accumulation in cognitively unimpaired beta-amyloid negative Alzheimer’s disease patients as well as those with mild cognitive impairment who were Aβ+ at baseline. ....

Australian Dementia Network Adne , Australian Dementia Network , Australian Imaging Biomarkers , Discovery Industry Focus , Alzheimer 39s Disease , Positron Emission Tomography ,

Alterity Therapeutics Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office

/PRNewswire/ Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying. ....

United States , France General , San Francisco , Languedoc Roussillon , David Stamler , Trademark Office , Research Group , National Institute Of Health , Parkinson Foundation , Alterity Therapeutics , United States Patent , Chief Executive Officer , Australian Imaging Biomarkers , Neurological Disorders , Disease Information Page ,

Alterity Therapeutics : Announces Allowance of New Composition of Matter Patent by the United States Patent and Trademark Office - Form 6-K

Alterity Therapeutics Announces Allowance of New Composition of Matter
Patent by the United States Patent and Trademark Office

- Patent covers more than 100 novel. | December 29, 2022 ....

United States , France General , San Francisco , Languedoc Roussillon , Remy Bernarda , David Stamler , Luiza Harrop , Research Group , Trademark Office , National Institute Of Health , Parkinson Foundation , Alterity Therapeutics , Alterity Therapeutics Announces Allowance , New Composition , United States Patent , Chief Executive Officer , Australian Imaging Biomarkers , Neurological Disorders , Disease Information Page , Media Contacts , Alterity Therapeutics Limited Stock Exchange , Press Release , 00 Ath Au0000043945 ,